A September 11 review in Neuroscience explores how photobiomodulation may influence excitation-inhibition regulation through mitochondrial, vascular and immune pathways. It brings experimental mechanisms and early clinical observations into one framework.
Why it matters This offers useful questions for research, not an established treatment protocol. Mechanistic plausibility does not prove clinical benefit or validate choosing light settings from an EEG profile.
Source and disclosure Narrative review, not a new clinical trial. Funding and conflicts were unavailable in the checked abstract. Prepared with AI assistance and verified against the authoritative indexed record on September 14, 2026.